Literature DB >> 1599936

Characteristics of substrates and inhibitors in binding to rat liver L-tryptophan 2,3-dioxygenase: a Fourier transform infrared and kinetic study.

K Uchida1, M Usami, H Bandow, I Harada.   

Abstract

Infrared spectroscopy and steady-state kinetics were applied to rat liver L-tryptophan 2,3-dioxygenase, in order to find relations between the structure and binding characteristics of its substrates and inhibitors. The binding characteristics were reflected by changes in the infrared CO stretch band(s) of an Fe(II)-CO complex of the enzyme upon addition of L-tryptophan and 12 analogs. The CO stretch band around 1961 cm-1 of the complex was not much affected by 1-methyl-D,L-tryptophan, a noncompetitive inhibitor, implying a binding at a site distant from the Fe(II)-CO vicinity. The spectral pattern was significantly changed by any of the other compounds which conserved an indole NH, indicative of its binding to the catalytic site. All substrates, which contained a complete CH(NH2)COOH group in addition to the NH, gave spectra similar to that of an L-tryptophan-bound complex. Spectral changes caused by six inhibitors, which lacked the complete CH(NH2)COOH, were different from one another and from those by the substrates. Hence, for an analog, the indole NH is indispensable to bind to the catalytic site, and the CH(NH2)COOH is important to take a correct configuration appropriate to the catalytic reaction. The reason why L- and D-isomers of 5-hydroxytryptohan are not substrates, in spite of their conservation of the required functional groups and correct binding to the catalytic site, has been ascribed to a possible distortion of the protein structure in the heme pocket due to a strong hydrogen bond from the hydroxyl group to an amino acid side chain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599936     DOI: 10.1016/0167-4838(92)90348-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.

Authors:  M Elizabeth Sublette; Hanga C Galfalvy; Dietmar Fuchs; Manana Lapidus; Michael F Grunebaum; Maria A Oquendo; J John Mann; Teodor T Postolache
Journal:  Brain Behav Immun       Date:  2011-05-14       Impact factor: 7.217

2.  Acyclovir inhibits rat liver tryptophan-2,3-dioxygenase and induces a concomitant rise in brain serotonin and 5-hydroxyindole acetic acid levels.

Authors:  Adrienne C Müller; Santy Daya
Journal:  Metab Brain Dis       Date:  2008-07-30       Impact factor: 3.584

3.  Probing the ternary complexes of indoleamine and tryptophan 2,3-dioxygenases by cryoreduction EPR and ENDOR spectroscopy.

Authors:  Roman M Davydov; Nishma Chauhan; Sarah J Thackray; J L Ross Anderson; Nektaria D Papadopoulou; Christopher G Mowat; Stephen K Chapman; Emma L Raven; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2010-04-21       Impact factor: 15.419

4.  Inhibition of Indoleamine 2,3 Dioxygenase Does Not Improve Cancer-Related Symptoms in a Murine Model of Human Papilloma Virus-Related Head and Neck Cancer.

Authors:  Elisabeth G Vichaya; Daniel W Vermeer; David Budac; Anna Lee; Aaron Grossberg; Paola D Vermeer; John H Lee; Robert Dantzer
Journal:  Int J Tryptophan Res       Date:  2019-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.